Search

It is of great significance to study the soil pore structure for soil reinforcement and ground treatment because it can be used to evaluate the solidification effect and explain the curing mechanism. The pore and compression characteristics of clay from Wuhan in China before and after solidification by ionic soil stabilizer (ISS) in different soil initial states were studied by the use of standard consolidation test, environmental scanning electron microscope analysis, specific surface area (SSA) test, and analysis by PCAS software. Results show that the influence sequence of soil initial states on the change of pore characteristics and ISS-solidification effectiveness was as follows: reducing initial water content + remolding soil > reducing initial water content > remolding soil > natural soil with high initial water content. Besides, loading can also increase the solidification effect. Compared to random and chaotic pore directions of natural clay, remolded solidified clay had a more certain direction after curing and compression. In addition, the total pore number and SSA decreased from 1190 to 756 by 36.47% and 109.690 m2/g to 87.837 m2/g by 19.92% respectively. Results indicate that ISS-clay solidification effect in practical engineering is closely related to the soil initial pre-curing state and can lead to the change of pore direction, decrease of pore number, reduction of pore size and porosity, and formation of larger aggregates. [ABSTRACT FROM AUTHOR]

Background: Although research on the effects of comorbidities on coronavirus disease 2019 (COVID-19) patients is increasing, the risk of cancer history has not been evaluated for the mortality of patients with COVID-19. Methods: In this retrospective study, we included 3232 patients with pathogen-confirmed COVID-19 who were hospitalized between January 18th and March 27th, 2020, at Tongji Hospital in Wuhan, China. Propensity score matching was used to minimize selection bias. Results: In total, 2665 patients with complete clinical outcomes were analyzed. The impacts of age, sex, and comorbidities were evaluated separately using binary logistic regression analysis. The results showed that age, sex, and cancer history are independent risk factors for mortality in hospitalized COVID-19 patients. COVID-19 patients with cancer exhibited a significant increase in mortality rate (29.4% vs. 10.2%, P < 0.0001). Furthermore, the clinical outcomes of patients with hematological malignancies were worse, with a mortality rate twice that of patients with solid tumors (50% vs. 26.1%). Importantly, cancer patients with complications had a significantly higher risk of poor outcomes. One hundred nine cancer patients were matched to noncancer controls in a 1:3 ratio by propensity score matching. After propensity score matching, the cancer patients still had a higher risk of mortality than the matched noncancer patients (odds ratio (OR) 2.98, 95% confidence interval (95% CI) 1.76–5.06). Additionally, elevations in ferritin, high-sensitivity C-reactive protein, erythrocyte sedimentation rate, procalcitonin, prothrombin time, interleukin-2 (IL-2) receptor, and interleukin-6 (IL-6) were observed in cancer patients. Conclusions: We evaluated prognostic factors with epidemiological analysis and highlighted a higher risk of mortality for cancer patients with COVID-19. Importantly, cancer history was the only independent risk factor for COVID-19 among common comorbidities, while other comorbidities may act through other factors. Moreover, several laboratory parameters were significantly different between cancer patients and matched noncancer patients, which may indicate specific immune and inflammatory reactions in COVID-19 patients with cancer. [ABSTRACT FROM AUTHOR]